Namsolleck, Pawel
Moll, Gert N. http://orcid.org/0000-0001-5762-5667
Article History
Received: 27 June 2020
Accepted: 11 August 2020
First Online: 17 August 2020
Ethics approval and consent to participate
: Not applicable.
: Both authors read and agreed to the content of the final manuscript, and consented on its publication.
: The authors disclose that their employer, LanthioPep B.V., is owner of patents on angiotensin variants. GNM is director of LanthioPep B.V..